144 related articles for article (PubMed ID: 30464326)
1. Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.
Wang J; Hidaka T; Sasaki Y; Tanaka E; Takagi M; Shibata T; Kubo A; Trejo JAO; Wang L; Asanuma K; Tomino Y
Sci Rep; 2018 Nov; 8(1):17157. PubMed ID: 30464326
[TBL] [Abstract][Full Text] [Related]
2. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
Zhang X; Qu X; Sun YB; Caruana G; Bertram JF; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(6):e67471. PubMed ID: 23840712
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
7. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
9. Synaptopodin Is Dispensable for Normal Podocyte Homeostasis but Is Protective in the Context of Acute Podocyte Injury.
Ning L; Suleiman HY; Miner JH
J Am Soc Nephrol; 2020 Dec; 31(12):2815-2832. PubMed ID: 32938649
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
Liao R; Liu Q; Zheng Z; Fan J; Peng W; Kong Q; He H; Yang S; Chen W; Tang X; Yu X
PLoS One; 2015; 10(7):e0132724. PubMed ID: 26161538
[TBL] [Abstract][Full Text] [Related]
12. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
13. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
14. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
15. Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.
Hosoe-Nagai Y; Hidaka T; Sonoda A; Sasaki Y; Yamamoto-Nonaka K; Seki T; Asao R; Tanaka E; Trejo JAO; Kodama F; Takagi M; Tada N; Ueno T; Nishinakamura R; Tomino Y; Asanuma K
Lab Invest; 2017 Nov; 97(11):1306-1320. PubMed ID: 28759006
[TBL] [Abstract][Full Text] [Related]
16. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
Yu H; Kistler A; Faridi MH; Meyer JO; Tryniszewska B; Mehta D; Yue L; Dryer S; Reiser J
J Am Soc Nephrol; 2016 Nov; 27(11):3308-3319. PubMed ID: 27020855
[TBL] [Abstract][Full Text] [Related]
17. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
18. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes.
Miao J; Fan Q; Cui Q; Zhang H; Chen L; Wang S; Guan N; Guan Y; Ding J
Nephrol Dial Transplant; 2009 Nov; 24(11):3297-305. PubMed ID: 19617259
[TBL] [Abstract][Full Text] [Related]
19. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
20. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
